High-throughput methylation sequencing reveals novel biomarkers for the early detection of renal cell carcinoma
Our findings highlight the critical role of hypermethylation in RCC etiology and progression, and present these identified biomarkers as promising candidates for diagnostic and prognostic applications.
Authors
- Tongning Zheng
- Hongyuan Huang
- Haobo Fan (ORCID: https://orcid.org/0000-0003-4022-0799)
- Jian Huang (ORCID: https://orcid.org/0000-0001-8117-1028)
- Hongcang Gu (ORCID: https://orcid.org/0000-0002-1439-7606)
- Xiaoyi Fei (ORCID: https://orcid.org/0009-0002-9533-112X)
- Guoqing Ding (ORCID: https://orcid.org/0000-0003-3156-3618)
- Qian Wang (ORCID: https://orcid.org/0000-0002-7766-824X)
- Yunfei Wang (ORCID: https://orcid.org/0000-0002-3899-1095)
- Jie Zhang (ORCID: https://orcid.org/0000-0002-1397-5224)
- Yi‐Cheng Chen (ORCID: https://orcid.org/0000-0002-7810-7145)
- Mingzhe Li (ORCID: https://orcid.org/0000-0002-4707-7588)
- Wenhao Guo (ORCID: https://orcid.org/0000-0003-0562-339X)
- Weiwu Chen (ORCID: https://orcid.org/0000-0002-8424-0735)
Institutions
- Chinese Academy of Sciences (CN)
- Sir Run Run Shaw Hospital (CN)
- Hefei Institutes of Physical Science (CN)
- Zhejiang University (CN)
Publication Details
- Journal
- BMC Cancer
- Published
- 2025-01-16
- DOI
- https://doi.org/10.1186/s12885-024-13380-6
- Citations
- 5
- Primary Topic
- Cancer Genomics and Diagnostics
- Type
- article
- Field-Weighted Citation Impact
- 4.68
Funders
- National Natural Science Foundation of China